2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
2024
Jun 28, 2024, 11:54 |
Career
Dr. Khaled Zaza appointed Head of Department of Oncology at Queen's University Faculty of Health Sciences
Bishal Gyawali shared on X: . "What an amazing happy…
Jun 28, 2024, 11:48 |
Blog
Patrick Hwu: Let us talk remote work on National Work From Home Day
Patrick Hwu shared a post LinkedIn: “Let us talk remote work on National Work From…
Jun 28, 2024, 11:47 |
Societies
Anwaar Saeed: Thrilled to present mature data from phase 2 CRC expansion cohort
Anwaar Saeed, Associate Professor and Chief of Gastrointestinal Medical Oncology at University of Pittsburgh, shared…
Jun 28, 2024, 11:43 |
Blog
Mafalda Oliveira discusses ESR1m ctDNA in MBC patients treated by camizestrant
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “For ESMO members: Breaking Science…
Jun 28, 2024, 11:28 |
Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 28, 2024, 11:27 |
Societies
12 Posts You Should Not Miss From Day 2 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 11:22 |
Blog
Richard Vines: An update on the work of Rare Cancers Australia in Asia
Richard Vines, Chair - Rare Cancers Australia, made the following post on LinkedIn: .…
Jun 28, 2024, 11:14 |
Blog
Aparna Parikh: Missing ESMOGI24 but for good reasons
Aparna Parikh shared on X: "Missing ESMOGI24 but for good reasons. Team PROSPECT (Yin Cao,…
Jun 28, 2024, 11:08 |
Insight
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results Authors: E. Felip, B.C.…
Jun 28, 2024, 11:02 |
Blog
Severine Guiu explains triple combination therapy for ER+/HER2- ABC with HRR deficiency or MSI - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: . “For ESMO members:…
618
619
620
621
622
All:
15390
Posts:
6191 - 6200
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube